Ginkgo Bioworks【DNA】株式ニュース

名称	銘柄コード	市場	種別
Ginkgo Bioworks Holdings Inc	DNA	NYSE	普通株式

	前日比	前日比 %	現在値	時刻
	0.0078	0.93%	0.8469	09:00:00

始値	安値	高値	終値	前日終値
0.8225	0.8039	0.8585	0.839	0.8391

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/16	23:31	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/16	02:24	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/15	20:01	PRNUS	Ginkgo Bioworks to Participate in Two Conferences in May
2024/5/15	07:00	PRNUS	Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use..
2024/5/14	23:48	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/14	05:14	EDGAR2	Form 8-K - Current report
2024/5/14	05:05	PRNUS	Ginkgo Bioworks Receives Continued Listing Standard Notice..
2024/5/13	23:50	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/10	23:10	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/10	06:16	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2024/5/10	05:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/10	05:02	EDGAR2	Form 8-K - Current report
2024/5/10	05:01	PRNUS	Ginkgo Bioworks Reports First Quarter 2024 Financial Results
2024/5/09	23:13	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/08	23:43	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/08	00:40	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/07	20:01	PRNUS	GreenLab Partners with Ginkgo Bioworks to Scale Up..
2024/5/07	05:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/07	05:53	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/06	23:43	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/06	20:01	PRNUS	Ginkgo Bioworks Announces Presentations at the Upcoming..
2024/5/02	20:00	PRNUS	Ginkgo Bioworks Announces Date of First Quarter 2024 Results..
2024/4/30	05:01	PRNUS	Ginkgo Bioworks Announces Nomination of Myrtle Potter and..
2024/4/16	20:02	PRNUS	Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic..
2024/4/11	20:01	PRNUS	Ginkgo Bioworks Previews Today's Annual Ferment Conference,..
2024/4/10	20:02	PRNUS	Ginkgo Bioworks and Novo Nordisk Expand Alliance to..
2024/4/10	20:01	PRNUS	Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of..
2024/4/08	20:00	PRNUS	IdeeLab Joins the Ginkgo Technology Network to Provide..
2024/4/04	20:01	PRNUS	Ginkgo Bioworks to Host 5th Annual Ferment Conference
2024/4/03	20:02	PRNUS	Prozomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme..
2024/4/02	20:02	PRNUS	Ginkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy..
2024/3/28	20:02	PRNUS	Ginkgo Bioworks Awarded DARPA Funding to Produce Novel..
2024/3/27	20:02	PRNUS	AQUA Cultured Foods Partners with Ginkgo Bioworks to..
2024/3/26	20:02	PRNUS	Imagindairy and Ginkgo Bioworks Collaborate to Develop and..
2024/3/12	20:01	PRNUS	CDC Traveler-based Genomic Surveillance Program to Expand to..
2024/3/12	20:00	GLOBE	CDC Traveler-based Genomic Surveillance Program to Expand to..
2024/3/11	23:55	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/09	06:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/09	06:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/09	00:27	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/08	00:09	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/07	07:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/07	00:04	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/06	02:42	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/05	09:43	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/05	02:28	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/02	04:18	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/01	07:03	EDGAR2	Form 8-K - Current report
2024/3/01	07:01	PRNUS	Ginkgo Bioworks Reports Fourth Quarter and Full Year 2023..
2024/3/01	02:46	EDGAR2	Form 144 - Report of proposed sale of securities